Medtronic (MDT) Change in Receivables (2014 - 2026)

Medtronic has disclosed Change in Receivables across 13 years of filings, most recently posting -$13.0 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$13.0 million, down 533.33% year-over-year; the trailing twelve-month figure through Jan 2026 was $162.0 million (down 62.76% YoY), and the FY2025 annual result was $433.0 million, up 10.74% from the prior year.
• Change in Receivables came in at -$13.0 million for Q1 2026 at Medtronic, down from $214.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $435.0 million in Q4 2022 to a low of -$288.0 million in Q3 2025.
• The 5-year median for Change in Receivables is $62.0 million (2023), against an average of $95.2 million.
• Across the five-year window, Change in Receivables jumped 232.06% in 2022 and plunged 533.33% in 2026, its largest moves.
• Medtronic's Change in Receivables stood at $435.0 million in 2022, then slumped by 35.4% to $281.0 million in 2023, then increased by 3.56% to $291.0 million in 2024, then fell by 26.46% to $214.0 million in 2025, then tumbled by 106.07% to -$13.0 million in 2026.
• The last three Change in Receivables figures came in at -$13.0 million (Q1 2026), $214.0 million (Q4 2025), and -$288.0 million (Q3 2025), per Business Quant data.